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Abstract 
Moncivaiz, Jessica Danielle. M.S., Biochemistry and Molecular Biology M.S. Program, 
Wright State University, 2015. Differences in fecal metabolite profiles from 
geographically distinct populations of adolescents.   
 Microbiota of the gastrointestinal tract have a variety of functions within the 
human body. They participate in protection of the host from pathogens, aid in immune 
system development and regulation, and carry out a variety of metabolic functions. This 
study focuses on the ability of gut microbiota to create metabolites through the 
degradation of food products. Using 
1
H NMR on fecal water extracts, I compared the 
metabolite profiles of two geographically distinct cohorts: healthy adolescents from 
Egypt (n=28) and healthy adolescents from the United States (n=14). Multivariate 
statistical analyses of binned NMR data confirmed that samples separated into groups 
corresponding to sample class. Quantification of metabolites revealed several metabolites 
that differed between groups. For example, levels of short chain fatty acids were higher in 
the Egyptian adolescents and most quantified amino acids were higher in the US 
adolescents. Multivariate statistical analyses of the quantified metabolite data showed 
separation based on the variability within the samples and placed samples into the correct 
class. Therefore, I concluded that fecal metabolite profiles differ between Egyptian and 
United States adolescents, and that these differences in metabolite levels may be linked to 
dietary differences between these two studied cohorts.  
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1. Introduction 
Microbes 
Microbes are very diverse organisms that cannot be seen by the naked eye but are 
abundant in every environment on earth. They have the capability to thrive in air, soil, 
rock, and even water [1]. They can be classified into six different groups’: bacteria, 
viruses, fungi, protozoa, algae, and archaea [2]. Many communities of microbes are 
located in these different environments, ranging from hundreds to even thousands of 
species [3]. These communities are important for a variety of ecosystem processes 
including energy flow, element cycling, and biomass production. They can also play a 
role in energy and nutrient processing [3]. Due to the complex nature of these 
communities and their interactions with the host and within themselves, attempts to 
analyze them have been challenging. 
 
Identification of microbes  
Despite the many challenges of studying microbes, researchers have made 
significant progress in understanding them through the advancements in molecular and 
high through-put technologies. Classical identification of microbiota located in areas like 
the gastrointestinal tract (GIT) have been studied through cultivation on Petri dishes. 
However, a lot of bacteria located in the GIT are hard to cultivate due their inability to 
survive aerobic conditions [4]. To obtain a broader view of the communities present in 
the GIT, molecular techniques have been developed for the sequencing of the small 
ribosomal subunit RNA (16S rRNA) gene. These approaches use polymerase chain 
reaction (PCR) primers, complementary to flanking conserved regions of the 16S rRNA 
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gene, selecting this gene for amplification and enriching it in a sample. The resulting 
amplicons are further scrutinized by certain variable regions to classify sequences into 
operational taxonomic units (OTUs) [5]. These OTU profiles allow scientists to 
differentiate between samples by analyzing the microbial community composition. These 
types of analyses are critical to better understand microbial functions and their 
relationships to human health.  
 
Microbes association with human health  
Microbiota-human interactions are generally thought to be beneficial to health, 
but can be harmful under certain conditions [6]. For example, the skin is normally 
inhabited by phyla of bacteria such as Actinobacteria, Bacteroidetes, Firmicutes, or 
Proteobacteria. This commensal bacteria of the skin can produce defense molecules or 
natural antibiotics to protect form pathogens [7]. However, increased colonization of S. 
aureus (a member of the Firmicutes phyla) can cause a chronic, inflammatory infection 
called atopic dermatitis (AD) [8].  According to a review by Wade, the human oral cavity 
is dominated by genera such as Actinomyces, Streptococcus, Neisseria, and Veillonella 
[9]. These commensal microbiota of the oral cavity defend against pathogens by 
colonization resistance and can also produce molecules to protect the host from infection. 
However, when species of microbiota that produce acid shift the microbiome in the oral 
cavity, dental carries (tooth decay) can occur and dissolve the tooth structure [9]. Finally, 
another important example of this interaction are the human GIT microbiota and their 
ability to interact with metabolites, which can contribute to host health. This relationship 
will be explained in much greater detail in the following sections.  
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Human gastrointestinal tract microbiota establishment  
 The human GIT is made up of epithelial cells, lamina propia, and muscularis 
mucosae and is home to around 10
14
 microbial cells [10]. The GIT microbiota are 
established at birth. Prior to birth the infants microbiota are undifferentiated across all 
body habits but based on the birthing method (vaginal or caesarian section) and the type 
of feeding (breast vs. formula) the developing microbiota can change composition [11]. 
Vaginally delivered infants’ GIT microbiota are dominated by genera such as 
Lactobacillus, Prevotella, and Atopobium, bacteria found in the vaginal canal, whereas 
infants born via C-section are dominated by Staphylococci, bacteria found on the skin 
[12]. After about a year, the infants microbiota profile starts to become similar to those of 
adults, having abundance of the phyla's Bacteroidetes and Firmicutes [13, 14]. These 
varying factors can contribute to a difference in microbial composition found within the 
GIT.  
 
Human gastrointestinal tract microbiota distribution and differences  
 Not only do gut microbiota profiles differ by age but they also differ with respect 
to the region of the GIT they inhabit. The GIT is a large muscular tube that includes the 
mouth, esophagus, stomach, small intestine (duodenum, jejunum, and ileum), and large 
intestine (appendix, cecum, colon, and rectum) [15]. The microbiota differ due to 
physicochemical conditions such as pH, motility, redox potential, nutrients, and 
secretions by the host. As the GIT progresses through the body the microbial cell density 
(per gram of intestinal content) increases from 10
1
-10
4 
cells in the stomach and 
duodenum, 10
4
-10
8 
cells in the jejunum and ileum, and 10
10
-10
12 
cells in the colon [16]. 
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Along with the density increase the type of bacteria present in various sections of the GIT 
is different. For example, in a study done by Frank et. al., the colon and small intestines 
were analyzed and found to have different microbiota compositions. The small intestine 
had a higher abundance of Bacillus and a lower abundance of Bacteroidetes and family 
Lachnospiraceae [17]. Overall, compared to the large intestine the small intestine 
contained less phylogenetic diversity of Bacteroidetes and Firmicutes [17]. Differences 
within the sections of the GIT can cause a difference in microbiota composition.  
 
Functions of microbiota of the gastrointestinal tract 
 The microbiota of the GIT have many critical functions including protection 
against pathogens, development of the immune system, and metabolic functions. For 
example, commensal bacteria protect the gut environment from pathogenic bacteria 
through competitive inhibition [10]. The commensal bacteria also produce toxins and 
metabolites that can inhibit or stunt the growth of potential pathogenic bacteria. If this 
protective layer of commensal bacteria is disrupted by antibiotics then pathogenic 
bacteria such as Clostridium difficile can colonize and flourish. This bacteria can cause 
pathophysiological conditions such as Clostridium difficile infection (CDI) which 
presents symptoms like diarrhea, nausea, and abdominal cramping for the host [18]. 
Therefore, the competitive environment against pathogenic bacteria established by the 
commensal bacteria is very important for the health of the host.  
 Another function of the GIT microbiota is its role in the development of the 
immune system and response. The gut immune system consist of peyer's patches, lamina 
propia lymphocytes, intra-epithelial lymphocytes, and mesenteric lymph nodes that have 
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gut-associated lymphoid tissue (GALT) [10]. IgA, an important immunoglobulin secreted 
into the GIT can coat and protect commensal bacteria and also respond to pathogens on 
mucosal surfaces. It has been shown that IgA is important for maintaining GIT 
microbiota homeostasis and composition [19]. A study by Suzuki et. al., showed that 
mice with a deficiency of activation-induced cytidine deaminase (AID) produced more 
IgM than IgA. This dysregulated the GIT microbiota community and caused increase 
activation of GALT [19]. Dysregulation of the immune system can result in further host 
related problems, including a variety of autoimmune diseases. 
 Microbiota are also important for a variety of metabolic functions due to their 
ability to create metabolites and vitamins that can be used by the host through the 
degradation of various food products. For example, a review by Tremaroli et. al. showed 
GIT microbiota can degrade non-digestible carbohydrates, that cannot be degraded earlier 
in the GIT by the host, including cellulose, xylans, resistant starch, and inulin [20]. The 
end products of this metabolism creates short chain fatty acids (SCFAs) acetate, 
propionate, and butyrate [20]. Peptides and proteins can also be metabolized by GIT 
microbiota to produce amino acids, SCFAs, and even some toxic substances such as 
ammonia and indols [21]. Gut microbiota can also metabolize dietary products, such as 
choline, into methylamines [11]. Understanding the ability of microbiota in the GIT to 
regulate metabolic functions can help researchers to better understand their impact on 
overall human health.  
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Metabolite functions and importance in human health 
Short chain fatty acids 
 
 A review by Macfarlane et. al. highlights SCFAs as a major metabolic end 
products produced in the human large intestine by bacteria [22]. They are primarily 
produced from digestion of polysaccharides, oligosaccharides, and proteins [20]. 
Enzymes degrade these large macromolecules and allow the microbiota to ferment the 
sugars. Fermentation substrates can include starches and plant cell-wall polysaccharides 
(celluloses, pectins, and xylans) that are not degraded or absorbed in the small intestine. 
The main SCFAs produced by this fermentation are acetate, propionate, and butyrate. 
However, other SCFAs such as formate and valerate are formed during catabolism of 
branched-chain amino acids [20]. Even lactate, ethanol, and succinate, can to some 
extent, be metabolized into SCFAs in the GIT [22]. 
 SCFAs have many effects in the host and have been implicated in several health 
benefits. SCFAs can be used by the host as energy substrates for colonic epithelium, 
peripheral tissues inflammation modulators, vasodilators, and promote wound healing 
[20]. More specifically, butyrate enhances fatty acid oxidation and thermogenesis in 
muscle and liver tissue [23]. Propionate and butyrate are known to activate intestinal 
gluconeogenesis which promotes metabolic benefits on weight and glucose control [23]. 
Acetate can reduce appetite by changing expression of neuropeptides through the 
activation of the tricarboxylic acid cycle (TCA) [23].  
 SCFAs have also been shown to have anti-inflammatory and anti-cancer 
properties by several studies. The anti-inflammatory property of SCFAs could be used as 
a potential treatment of gastrointestinal inflammatory diseases such as Crohn’s disease 
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and inflammatory bowel disease (IBD) [24]. In a study done by Tedelind et. al., they 
found that SCFAs inhibit lipopolysaccharide-stimulated release of tumor necrosis factor 
alpha (TNF ), a cytokine involved in systemic inflammation in human neutrophils. They 
also showed that SCFAs inhibited the NF-kB pathway, an inflammatory pathway 
activated by cytokines [24]. Other studies have shown SCFAs role against colon cancer.  
For example, studies have shown that SCFAs act as ligands for G-protein coupled 
receptors like GPR43, which are found in normal human colon tissue. In a study done by 
Tang et. al., they showed that GPR43 expression was lower in human colon cancer cell 
lines. However, when they restored GPR43 in colon cancer cells along with the presence 
of propionate, it retarded growth and increased apoptosis [25]. SCFAs have the capability 
to promote positive health effects and could be used as a potential treatment for 
inflammatory GIT diseases.   
Amino acids 
Proteins can also be degraded in the large intestine by certain proteolytic 
microbiota species into amino acids. Proteins that aren’t broken down earlier in digestion 
reach the colon, where bacterial proteases and left over pancreatic endopeptidases break 
them down into amino acids. Around 12 grams of proteinaceous material enters the colon 
a day,  49-51% coming from protein and 20-30% coming from peptides [26]. Protein can 
be further broken down by hydrolysis creating amino acids groups such as aromatic, 
sulfur, and other amino acids. Then amino acids can be broken down into other 
compounds. Aromatic amino acids like tryptophan go through an elimination reaction 
and become phenolic and indolic compounds, while other amino acids can go through 
deamination, decarboxylation, or fermentation which create ammonia, amines, or other 
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organic acids [27]. The protein that makes it to the colon is believed to come from around 
50% of dietary sources and levels can vary based on certain foods [26].  
High protein intake from food products such as meat has been linked by several 
studies to certain diseases. When meat is cooked it creates N-nitroso compounds (NOCs), 
heterocyclic amines (HCAs), and polycyclic aromatic hydrocarbons (PAHs); all these 
compounds are cacogenic and can cause DNA damage [28]. Also wide variety of cancers 
(colorectal cancer, lung cancer, liver) have been associated with red meat and processed 
meat intake [29]. In a study done by Smolinska et. al., researchers performed meta-
analysis on seven cohort studies that took place from 1994-2007 to determine risk of 
colon cancer. They found that red meat intake of over 50 g/day can cause colonic 
carcinogenesis and red meat intake more than once per day can cause colonic and rectal 
cancers [28]. Another study done by Pan et. al., linked red meat to increased risk of type 
2 diabetes (T2D). This study followed three different cohorts of over 4 million US 
citizens’, male and female. The researchers accessed red meat consumption (processed 
and unprocessed) and T2D by questionnaires. Using statistics and meta-analysis they 
found a positive correlation between T2D and red meat consumption [30]. Amino acids 
especially from intake of meat products can cause a variety of disease that are harmful to 
the host.  
Bile acids 
Bile acids are important regulators for cholesterol balance and for 
digestion/absorption of lipids within the small intestine. They act as emulsifiers of lipids 
and fat-soluble vitamins and are the primary mediators of cholesterol catabolism. When 
bile acid synthesis occurs in the liver, primary bile acids such as cholic acid and 
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chenodeoxycholic acid (CDCA) are formed. Before bile acids are stored in the 
gallbladder as micelles with phospholipids and cholesterol, primary bile acids are 
conjugated with taurine or glycine to enhance hydrophilicity. After a meal is ingested the 
gallbladder releases the bile acids into the intestinal lumen to help with digestion of food 
products. When bile acids reach the GIT around 5-10% are deconjugated by the 
microbiota to create secondary bile acids such as deoxycholic and litocholic acids (DCA, 
LCA), and can then be reabsorbed or eliminated in the feces [31].  
Bile acids have been implicated as possible causative agents for various cancers 
of the GIT and have been shown to be involved in inflammatory pathways in GIT cells. 
Individuals on high fat diets have been shown to have high amounts of bile acids and this 
can cause cells to be exposed to reactive oxygen species (ROS) and reactive nitrogen 
species (RNS). These agents can cause DNA damage, increased mutations, and apoptosis 
which could lead to various GIT cancers [32]. In a study by Bernstein et. al., mice were 
fed a diet that had high physiological levels of DCA, a common bile acid found in feces, 
to see if it had the potential to induce colon cancer. DCA was given to the mice for 8-10 
months, DCA induced colonic tumors in 17 of the 18 wild type-mice [33]. Another study 
by Schlottman et. al., showed that bile acids had the ability to cause apoptosis in human 
colon cancer cell lines. Looking at HT-29, Caco-2, and SW480 colon carcinoma cell lines 
they found that varying concentrations of DCA caused apoptosis. They also showed 
caspase cleavage and activation, molecules responsible for biochemical change in cells 
undergoing apoptosis, occurred after the addition of deoxycholate [34]. Another study by 
Morbraten et. al., showed that triggering TGR5, a bile acid cell surface receptor, 
enhances lipopolysaccharide inflammatory response in monocytic cell lines. Bile acids 
10 
 
DCA and CDCA, activated MAP kinases ERK 1/2, p38, and JNK, major pathway 
activated by stress and inflammation. They also activated NF-kB signaling (inflammation 
pathway) and the release of inflammatory cytokines. The researchers believe that since 
LPS may contribute to insulin resistance, that TGR5 activation may also play a role [35]. 
This gives evidence that bile acids can have damaging effects on cells and their potential 
to lead to a variety of cancers.  
Taurine  
 Taurine is an important dietary nutrient often referred to as a semi-essential amino 
acid (even though it lacks a carboxyl group) because mammals have limited ability to 
synthesize taurine and have to get it through their diet [36]. Taurine is acquired through 
the synthesis of cysteine and methionine, through absorption of food, excretion of 
taurocholate (bile salt), or unconjugated taurine in the urine. The taurine source in the 
intestines is mainly from the deconjugation of bile acids (taurocholic acid, 
taurochenodeoxycholic acid) by GIT microbiota through bile salt hydrolases [11]. 
Taurine has been shown to be important in many biological functions of the body. 
Taurine has a zwitterionic capability making it highly soluble in water and low 
lipophilicity. These properties contribute to taurine’s membrane impermeability, high 
dipole nature, interactions with cations, membrane modulatory, and conjugation with bile 
acids. It has also been shown in studies to play a role in post-translational modification of 
mitochondrial tRNAs. High taurine levels can be found in foods such as beef, pork, fish, 
and shellfish [36]. It has also been shown to be high in energy drinks [36].  
 Taurine is an important nutrient in the body for normal function but when 
combined or taken in high amounts can cause adverse health problems. When the taurine 
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transporter (TauT) is knocked out in mice many health problems can occur such as 
reduced exercise capability, loss of retinal photoreceptor function, degeneration of the 
inner ear, cardiomyopathy, reduced T-cell memory generation, and hepatitis/liver 
fibrosis. Taurine can regulate cell volume, contribute to pool of organic osmolytes, 
stabilize membranes, serve as an antioxidant, and has anti-inflammatory/anti-apoptotic 
effects [36]. Taurine has also been shown to have adverse effects especially when 
combined with caffeine or in the high amounts present in energy drinks. It has been 
reported to increase systolic blood pressure and increase heart rate. Long term taurine 
consumption has also been implicated in human and animal studies to cause 
hypoglycemia [37]. 
Choline  
 Choline is a water soluble nutrient that is utilized in many pathways in the body. 
Choline can be obtained in the diet through foods such as eggs, liver, meats, and wheat 
germ or produced endogenously [38]. Choline is a key component to make membrane 
phospholipids, used as a methyl donor in the betaine production, and it is acetylated to 
make acetylcholine, an important neurotransmitter [39]. Choline can also influence other 
processes such as lipid metabolism, activation of nuclear receptors, circulation of bile and 
cholesterol, plasma membrane fluidity, and the bioenergetics of mitochondria. Dietary 
choline has been shown to be excreted in urine as N, N-dimethylglycine and leads to the 
production of creatine and creatinine. It can also be converted into methylamines by GIT 
microbiota after high fat consumption [40].  
 Choline has been associated with several health issues including liver and 
cardiovascular disease. In a study done by Sha et. al., they found that metabolomics 
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profiling of choline and related metabolites were able to predict which participants fed a 
certain diet (high or low choline) would develop liver dysfunction. They found that of the 
53 patients, 9 developed liver dysfunction or muscle dysfunction when given a diet low 
in choline and 23 participants developed hepatic steatosis (fatty liver) [39]. Another study 
by Dumas et. al., mice fed a high fat diet had reduced bioavailability of choline. This is 
because the GIT microbiota converted the choline into methylamines (trimethylamine, 
dimethylamine, trimethylamine-N-oxide) which mimicked effects of a choline-deficient 
diet and caused non-alcoholic fatty liver disease (NAFLD) [40]. Choline is needed by our 
bodies for a variety of functions and can protect from disease like NAFLD.  
 
Nuclear magnetic resonance use in metabolomics 
 Nuclear magnetic resonance (NMR) spectroscopy is the measurement of 
absorption or emission of frequency energy by nuclei in a magnetic field. The output of 
this process is specific resonances (peaks) that correspond to different compounds. NMR 
spectroscopy is a dynamic tool that is nondestructive, capable of identifying structural 
and conformational analyses of complex molecules, and can quantitate complex mixtures 
of molecules [41]. NMR spectroscopy has recently been shown as a useful technique in 
metabolite analyses, especially in the metabolic profiling of biofluids (such as fecal 
material). The reasons it is so effective is because it requires little to no sample 
preparation and is nondestructive/noninvasive to the sample [42]. These qualities make 
NMR a great technique to use for metabolite profiling. 
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Metabolite profiling of the human gut 
 In order to gain a better understanding of the impact of nutrition on the human gut 
microbiome Jacobs et. al., introduced the idea of 
1
H NMR metabolite profiling of feces. 
In this study the researchers’ first generated metabolite profiles by water and methanol 
extraction of lyophilized feces and they obtained a variety of metabolites e.g. amino 
acids, SCFAs, organic acids (e.g. succinate, pyruvate), uracil, ethanol, cholate, and 
glucose [43]. Then to validate this approach they did another study where they placed 
human subjects on either a placebo, grape juice extract, or grape juice wine extract for 4 
weeks. The goal of the researchers was to see if metabolite profiles of feces changed 
based on dietary changes. They found that the grape juice extract did not change the 
metabolite profiles of individuals compared to the placebo. However, the individuals 
placed on the grape juice wine extract did cause a reduction in isobutyrate [43]. Another 
study similar to Jacobs et. al., was performed by Ndagijimana et. al., looking at effects of 
synbiotic food on the metabolite profiles of the gut using 
1
H NMR. They feed 16 healthy 
subjects synbiotic food for a month and looked at the difference prior to consumption and 
after consumption. They were able to detect 150 metabolites and the biggest changes 
between start and end of diet was that SCFAs increased and amino acids decreased [44]. 
These studies show the efficiency of 
1
H NMR metabolic profiling on fecal material to 
determine differences based on dietary changes.  
 
 
 
14 
 
Metabolite differences related to geography and regional diet 
 Differences in metabolites and microbiota can also be determined by geographical 
location and what foods are available in those different locations. A study done by De 
Filippo et. al., compared the fecal material between two groups of adolescents: an African 
group called the Mossi from Burkina Faso (BF) and European adolescents from Florence, 
Italy (EU). The BF diet is low in fat and animal protein but rich in starch, fiber, and plant 
polysaccharides. The EU diet is rich in animal protein, sugar, starch, and fat but low in 
fiber. The researchers found that the groups had enrichment of certain GIT bacteria that 
are known to degrade polysaccharides and BF adolescents had significantly more SCFAs 
compared to the EU. They believe these differences are due to their differing diet [45].  
Another study, done by Schnorr et. al., compared metabolites and microbiota 
from the Hadza hunter gatherers from Tanzania and adults from Bologna, Italy. The 
Hadza diet consists of wild foods such as meat, honey, baobab, berries, and tubers. As 
where the Italian cohort’s diet followed more of a Mediterranean diet consisting of plant 
foods, fruit, pasta, bread, and olive oil. The Italian cohort dietary source of carbohydrates 
mostly came from digestible starch and sugar, with little indigestible fiber. The study 
showed the Hadza group has higher microbial richness and diversity than the Italian 
group. The Hadza group also had a higher enrichment of bacteria involved with the 
digestion of fibrous plant foods. The researchers also found that Italian samples had 
higher levels of butyrate and the Hazda had higher levels of propionate [46].  
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Differences between U.S. and Egyptian diets  
In this study, we profiled metabolite differences of Egyptian and US teenagers. 
Diets of these two populations are thought to be different which can impact GIT 
microbiota. Figure 1.1 and 1.2 give an overview of the main diet differences between 
Egyptians and United States adolescents. 
Figure 1.1: Egyptian diet 
 
 
 
 
 
 
 
 
Figure 1.2: United States diet 
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Figure 1.2 shows foods of high and low intake in the United States diet 
Figure 1.1 shows foods of high and low intake in the Egyptian diet 
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According to a review published by H. Hassan-Wassef explaining the basic 
features of the Egyptian diet; bread made from wheat flour is one of the main food staples 
in the Egyptian diet and eaten with almost every meal. Cereals and legumes are also very 
popular in the diet and are the main source of calories and protein. Egyptians regularly 
intake fresh dark green leafy vegetables such as cabbage, spinach, and grape leaves. Also 
small amounts of cheese and dairy products are consumed regularly. Meat consumption 
is lower because it tends to be regarded as a luxury item and due to religious and cultural 
reasons cannot be consumed at certain times. Egyptian diet is traditionally low in 
saturated fats and oil is more commonly used than butter [47]. 
 The United States diet patterns vary from that of the Egyptians. According to a 
review published by D. Grotto on the US diet, there are foods eaten in excess and foods 
under-consumed by the US population. These numbers are calculated based on a 2,000 
kilo-calorie per day intake recommended by the Dietary Guidelines for Americans 
(DGAs) created by the United States Department of Agriculture (USDA) and U.S. 
Department of Health and Human Services. It is recommended that Americans eat 
6ounce-equivalents (oz-eq) of grain per day, however it has been shown that they eat 8.1 
oz-eq per day. Most of these grains are refined (7.2 oz-eq) and not the recommended 
whole grains. It is suggested to ingest 4.5 cups of fruits and vegetables (leafy green, 
legumes, orange, and starchy vegetables) per day; 2 cup from fruit and 2.5 from 
vegetables. The US population is currently consuming 0.9 cups of fresh and processed 
fruit and 1.7 cups of fresh and processed vegetables. Dietary fiber recommended intake is 
around 28g per day but the US population only consume 15.2 g per day. Meat and beans 
(not including legumes), however are over consumed. It is recommended 5.5 oz-eq per 
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day, and actual intake is 6.5 oz-eq per day. The recommended total intake of fat to be 
between 25%- 35% of total calories a day. American’s have been shown to consume 
around 71.6g of added fats and oils per person per day [48]. 
 
Thesis overview  
The work in this thesis involved the comparison of metabolite profiles of two 
geographically distinct cohorts, healthy Egyptian adolescents (n=28) and healthy United 
States adolescents (n=14). Fecal water extracts to obtain water soluble metabolites were 
made from collected fecal samples and 
1
H Nuclear Magnetic Resonance (
1
H NMR) on 
the extracts was performed by Dr. Nicholas Reo’s Laboratory at Wright State University, 
Dayton, Ohio. The binned NMR data obtained from the 
1
H NMR were ran through 
multivariate statistical tools to determine differences between samples. Next, applying 
spectrum deconvolution, a method for differentiating peaks of interest, quantification of 
32 metabolites was done. Metabolite peak validation procedure (spike-in) was used to 
confirm peak assignments for metabolites with suspect peaks. Finally, after confirmation 
and quantification of all the metabolites, the metabolite data was transformed to center-
log ratio and multivariate statistical tools were ran.   
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2. Materials and Methods 
Sample Collection 
 Samples were collected from two different groups; healthy adolescents from 
Egypt (egkHLT) and healthy adolescents from the United States (uskHLT). egkHLT 
samples were collected by Dr. Laila Hussein from The National Research Center located 
in Giza Governorate, Egypt and uskHLT samples were collected by Dr. Oleg Paliy’s 
laboratory and Dr. Sonia Michail’s at Wright State University and Dayton Children’s 
Hospital located in Dayton, Ohio. Volunteers defecated into sterile collection containers 
that were then immediately stored at -80℃. The cohort consisted of 28 male samples 
from egkHLT and 14 male samples from uskHLT. Table 2.1 and 2.2 details sample 
name, age, gender, and BMI 
2.1: Volunteer information for uskHLT samples  
Sample (uskHLT) Age BMI 
uskHLT05 12 19.9 
uskHLT08 15 22.1 
uskHLT13 10 22.6 
uskHLT14 11 23.8 
uskHLT17 10 17.2 
uskHLT20 12 21.5 
uskHLT22 18 25.6 
uskHLT24 16 16.7 
uskHLT26 10 17.3 
uskHLT27 9 18.4 
uskHLT29 12 26.5 
uskHLT30 14 18.4 
uskHLT31 15 25.8 
uskHLT32 16 20.4 
Average 13.0 ± 0.7 21.2 ± 0.9 
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Table. 2.2: Volunteer information for egkHLT samples 
Sample (egkHLT) Age BMI 
egkHLT01 14 19.5 
egkHLT02 15 23.7 
egkHLT03 14 22.0 
egkHLT04 14 17.6 
egkHLT05 15 21.8 
egkHLT06 13 17.3 
egkHLT07 14 17.4 
egkHLT08 13 17.3 
egkHLT10 14 16.9 
egkHLT11 13 15.5 
egkHLT12 13 17.3 
egkHLT14 14 18.9 
egkHLT15 14 17.3 
egkHLT16 14 16.9 
egkHLT17 14 18.2 
egkHLT19 13 19.6 
egkHLT20 15 17.5 
egkHLT22 14 19.2 
egkHLT23 15 24.5 
egkHLT24 14 17.9 
egkHLT25 13 17.1 
egkHLT26 14 15.6 
egkHLT27 14 17.7 
egkHLT28 14 18.0 
egkHLT29 14 19.9 
egkHLT30 14 25.5 
egkHLT31 14 20.3 
egkHLT32 14 19.2 
Average 14.0 ± 0.1 18.9 ± 0.5 
 
Fecal water extraction 
Fecal water extractions were performed to obtain water soluble metabolites for 
1
H 
NMR. The phosphate buffer solution used in the protocol contained 2.0 mg KCl, 11.5 mg 
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Na2HPO4-7H2O, 2.0 mg KH2PO4, and 10 ml H2O. After the phosphate buffer was made 
the fecal water extraction protocol was performed. The protocol is the following: 
a) 250 mg of fecal sample was weighed and placed in 2 ml eppendorf tubes 
b) 1.25 ml of 1x phosphate buffer was added to the tube and vortexed at maximum 
speed for 5 minutes to homogenize samples 
c) The homogenized samples were centrifuged at maximum speed in the 
chromatography fridge for 5 minutes at 1600g in 4 ℃ 
d) Supernatant was collected and filtered through Whatman GDX filter using a 
syringe and eluted into a 1.5 eppendorf tube 
e) Eluate was centrifuged in the chromatography fridge for 15 minutes at 1600g in 4 
℃ 
f) The supernatant was aliquoted into two clean 1.5 ml eppendorf  tubes and placed 
in the -70℃ freezer 
 
Proton nuclear magnetic resonance 
1
H NMR analysis of fecal water 
extracts 
Proton NMR was done to determine metabolite composition within the collected 
fecal samples. This was carried out by Dr. Nicholas Reo’s Laboratory at Wright State 
University in Dayton, Ohio. A 550-600 μl aliquot of the fecal extract sample was 
transferred into a 5 mm NMR tube with 150 μl of 9 mM trimethylsilypropionic-2.2, 3, 3-
d4acid (TSP) in D2O. 
1
H NMR spectra were acquired at 25 ℃ using a Varian INOVA 
operation at 600 MHz (14.1 Tesla). The TSP was a chemical shift standard used for 
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reference and quantification. The spectra were pre-processed using a standard protocol 
employed in Dr. Reo’s laboratory [49]. 
To use this data for multivariate analyses, the spectral data are binned. Binning is 
the process of dividing the spectrum into several hundred non-overlapping regions of the 
same size. Binning attempts to lessen the effects of variation in peaks position that can be 
caused by pH, ionic strength, composition, and reduce the dimensionality for multivariate 
statistical analyses [50]. The method for binning on the data set is a dynamic 
programming-based adaptive binning technique developed by Anderson et al 2011 and 
was carried out by Dr. Reo’s laboratory [50].  
 
NMR spectrum deconvolution  
Deconvolution algorithm was employed in MATLAB R2014a (Mathworks Inc) to 
determine peak areas of the 32 selected metabolites [50]. The purpose of deconvolution is 
to identify known peaks from other peaks that can overlap in the same region. The 
deconvolution software works by fitting a defined spectral region using a combination of 
baseline shapes (spline, v-shaped, linear, or constant) and a Gauss-Lorentz peak-fitting 
function. Figure 2.1 shows an example (uracil, ppm ~ 5.80) of the deconvolution process 
before the line fitting and peak validation and Figure 2.2 is after the line fitting and peak 
validation by the user. After deconvolution is done a better estimate of the peak area can 
be determined. Areas for peaks of interest are outputted in text files. 
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Figure 2.1: Before deconvolution of uracil 
 
Figure 2.2: After deconvolution of uracil 
Figure 2.1 shows the spectrum of uracil before using the deconvolution algorithm to correct peak 
fitting. The two black arrows point to unfitted areas of the spectra.  
Figure 2.2 shows the spectrum of uracil after the deconvolution algorithm to correct peak fitting. 
The two black arrows point the areas that were fitted by the algorithm. 
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Metabolite quantification 
After deconvolution all the metabolite peak intensities were corrected for 
equivalent number of protons then normalized relative to TSP signal intensity through an 
excel template provided by Dr. Reo's laboratory. The extracts were prepared from 
identical stool weight so the relative comparisons between the samples were fully valid. 
Peak assignments are based on literature and databases (such as the Human Metabolome 
Database) [51]. 
 
Validation of metabolite peaks  
 Due to crowding of metabolite peak signals within some regions of the spectra a 
peak validation was done. Using sample uskHLT, four fecal water extracts following the 
same protocol were made. Next, nine 100 mM metabolite solutions at volume of 500 l 
were prepared, Table 2.3 shows the nine metabolites molecular weights and mass in the 
100 mM solution in milligrams. The final concentration was approximately 1.5 mM. 
Table 2.3: Molecular weights and mass of 100 mM solution in mg of each metabolite 
Metabolite  Molecular Weight g/mol Mass to obtain 100 mM Solutions (Volume) 
Isoleucine 131.2 6.6 
Leucine 131.2 6.6 
Tryptophan 204.2 10.2 
Glucose 180.2 9.0 
Methylamine 31.1 1.6 
Galactose 180.2 9.0 
Sucrose 342.3 17.1 
Uracil 112.1 5.6 
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The solutions were made with phosphate buffer and H2O. Uracil and tryptophan solutions 
were made with H2O and the other metabolite solution were made in phosphate buffer. 4 
l of NaOH was added to the tryptophan solution because tryptophan is more soluble in 
alkali hydroxides [52]. Then the fecal water extracts and metabolite solutions were given 
to Dr. Reo's Laboratory for 
1
H NMR analysis. Several metabolites were ran in each 
extract if their peaks did not overlap, Table 2.4 shows which metabolites were ran in the 
same extract.  
Table 2.4: Fecal water extract and contents 
Extract  Metabolites 
1 Leucine, Isoleucine, Methylamine, Tryptophan 
2 Glucose  
3 Sucrose 
4 Galactose, Uracil 
 
Statistical data analyses 
Analyses of the compositional 
1
H NMR binned and metabolite data was through 
multivariate analyses. Prior to multivariate analyses several processing steps on the 
binned and metabolite quantification data had to be done. First, sample-to-sample within-
group variance was reduced by normalization of binned data where egkHLT and uskHLT 
were auto-scaled to both group means [54]. Then center log ratio transformation (clr) 
using a custom script developed in our laboratory was performed on the metabolite data 
set. Since the data is compositional and is based on a relative scale, this transformation 
can remove the effect of constant-sum constrain on the co-varying variables [55]. The 
multivariate statistic tests used on this data set were principle component analysis (PCA), 
orthogonal projections to latent structures discriminate analysis (OPLS-DA), and 
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Random Forest (RF). PCA and OPLS-DA were ran in MATLAB R2014a (Mathworks 
Inc.) using custom scripts (Shankar et al 2013), and RF was ran in R x64 3.2.2 [49].  
PCA reduces dimensionality in the data set while retaining most of the variation 
by creating principle components. The principle components represent the variability 
within the data set and are re-ranked according to the amount of variation they represent, 
therefore PC1 would have the most variation, PC2 the second most and so on. This 
technique is unsupervised meaning that the tool is not told which samples belong to 
which groups [56]. PCA was developed in 1901 by Karl Pearson [57]. 
 OPLS-DA finds linear combinations of variables that separate groups. It is 
another technique that combines dimensionality reduction with a form of classification 
called discriminant analysis. It takes the variability of X that corresponds to Y and puts it 
in the T axis and takes the rest of the variability and puts it in the T orthogonal axis. The 
X data is the bins/metabolites and Y data is the class information. OPLS-DA is a 
supervised model meaning that it told which samples belong to which group. Q
2
 values 
are used to assess the predictive ability of the metric. As Q
2
 approaches 1 it means that 
the model exhibits predictive capability, however if it less than zero it means it has no 
predictive power [56]. OPLS-DA was developed by Trygg and Wold, 2002 [58].  
 Random forest is a method of classification that uses a collection of classification 
trees to provide variable importance. It works by using data that relies on random 
sampling with replacement (bootstrap) method and random variable selection to build the 
trees. RF creates a collection of trees that have low bias and low variance. Then RF then 
determines importance scores based on their mean gini scores. Random forest was 
developed by Leo Breiman in 2001 [59]. 
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 To evaluate statistical significance of metabolite levels, a Mann-Whitney U-Test 
was ran in SPSS (SPSS Inc.). 
 Correlations analysis was done to find the relationships among metabolites. To do 
this, SparCC, method and software established by Freidman and Alm was used [60]. 
First, correlations were found using the script in Python following these parameters –i 20 
inference iterations to average over, -x 10 number of exclusion iterations to remove 
strongly correlated pairs, and -t 0.1 correlation strength exclusion threshold. Second, to 
calculate pseudo p-values first the bootstrap procedure using the MakeBootstraps script 
was done generating 100 shuffled data sets. Next, SparCC was ran again (using the same 
parameters) on all 100 of these shuffled data sets to give two sided p-values.  
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3. Results 
Ordination analyses of binned data 
Principle component analysis  
 Figure 3.1 shows PCA carried out in MATLAB R2014a demonstrates that the 
samples could form two distinct clusters based on overall variability. A few samples did 
overlap into opposite clusters meaning that their variability identified more with their 
opposite classification. These samples were found to be uskHLT 29 being more related to 
egkHLT samples and egkHLT 14 being more related to uskHLT samples. The model's p-
value (p < 0.001) is statistically significant 
Figure 3.1 PCA plot of binned data 
 
 
 
 
 
 
 
 
 
 
 
 
 
p<0.001 
Figure 3.1 is the plot of principle components analysis of egkHLT 
(red) and uskHLT (green) samples. This data is based on the 
binned NMR data provided by Dr. Reo’s laboratory. 
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Orthogonal projection to latent structure discriminant analysis 
Figure 3.2 demonstrates that OPLS-DA had large group separation of T and little 
separation of T orthogonal. The model also demonstrates that the binned NMR data is 
separated into two groups and samples were placed in the correct groups. The models p-
value (p < 0.001) statistically significant. Q
2
 value was 0.81 meaning the model had 
strong predictive ability.  
Figure 3.2: OPLS-DA plot of binned data 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
p<0.001 
Figure 3.2 is the plot of orthogonal projection to latent structure 
discriminate analysis of egkHLT (red) and uskHLT (green) 
samples. This data is based on the binned NMR data provided by 
Dr. Reo’s laboratory. 
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Metabolite measurements 
 Using 
1
H NMR analysis, 32 metabolites were identified and the deconvolution 
algorithm was used to isolate individual metabolite peaks and allow robust quantification. 
These values calculated are arbitrary units respective to TSP, an internal chemical shift 
standard used in NMR. Tables 3.1-3.3 are all the metabolites identified in the egkHLT 
and uskHLT spectra with their chemical shift values in ppm. Figure 3.3 shows the 
egkHLT and uskHLT spectra with the peaks identified based on ppm.  
 
Table 3.1: Quantified SCFAs with chemical shifts in ppm  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short Chain Fatty Acids Chemical Shift 
1
H ppm 
Acetate 1.92 (s) 
Butyrate 1.56 (tq) 
Formate 8.46 (s) 
Propionate 1.06 (t) 
Valerate 0.86 (t) 
Table 3.1 shows the SCFAs identified and their peak 
locations along with peak type, (s) singlet, (d) doublet, 
(t) triplet, (dd) doublet of doublets, and (tq) triplet of 
quartets.  
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Table 3.2: Quantified amino acids with chemical shifts in ppm  
 
 
 
 
 
 
 
 
Table 3.3: Quantified metabolites with chemical shifts in ppm  
Other Metabolites  Chemical Shift 
1
H ppm 
1-Methylhistamine 3.25 (t) 
Cholate Bile Acids 0.73 (m) 
Choline 3.20 (s) 
Cytosine 7.52 (d) 
Ethanol 1.19 (t) 
Fumarate 6.52 (s) 
Galactose 5.27 (d) 
Glucose 5.24 (d) 
Hypoxanthine 8.22 (s) 
Lactate 1.33 (d) 
Malate 4.30 (dd) 
Methylamine 2.61 (s) 
Pyruvate 2.47 (s) 
Succinate 2.41 (s) 
Sucrose 4.22 (d) 
Taurine 3.45 (t) 
Trimethylamine 2.90 (s) 
Uracil 5.80 (d) 
Amino Acids Chemical Shift 
1
H ppm 
Alanine 1.48 (d) 
Aspartic Acid 2.82 (dd) 
Glycine 3.56 (s) 
Isoleucine 1.01 (d) 
Leucine 0.96 (t) 
Lysine 3.03 (t) 
Tryptophan 7.54 (d) 
Tyrosine 6.90 (m) 
Valine 3.61 (d) 
Table 3.3 shows the other metabolites identified and their 
peak locations along with peak type, (s) singlet, (d) doublet, 
(t) triplet, and (dd) doublet of doublets. 
Table 3.2 shows amino acids identified and their peak 
locations along with peak type, (s) singlet, (d) doublet, 
(t) triplet, and (dd) doublet of doublets  
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Figure 3.3:
1
H NMR spectra of egkHLT and uskHLT 
 
Figure 3.3 shows the spectra acquired by the 
1
H NMR of egkHLT (red) and uskHLT (green) samples along with the 
identification of the 32 metabolites peaks 
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Short chain fatty acids 
 Table 3.4 shows the quantified (arbitrary units respective to TSP) SCFAs values. 
Overall, the SCFAs are higher in egkHLT compared to uskHLT. Acetate, butyrate, and 
propionate are all higher in egkHLT.  However, formate and valerate are higher in 
uskHLT. Mann-Whitney U-Test indicated that differences in acetate, propionate, and 
SCFAs total were statistically significant (p≤0.05). 
Table 3.4: Short chain fatty acids quantification results  
Metabolite egkHLT ±SE uskHLT ±SE Mann-Whitney U Test 
Acetate 42.12 0.72 38.36 1.49 0.040 
Butyrate 16.04 0.65 15.15 1.02 0.471 
Formate 0.55 0.03 0.60 0.06 0.594 
Propionate 23.25 0.56 19.66 1.27 0.008 
Valerate 1.17 0.13 1.39 0.22 0.455 
Total 83.29 1.04 75.10 2.38 0.001 
 
 
 
Amino acids 
 Table 3.5 shows the quantified (arbitrary units respective to TSP) amino acid 
values. Amino acid totals are higher in uskHLT compared to egkHLT. Alanine, aspartic 
acid, isoleucine, leucine, lysine, tyrosine, and valine are all higher in uskHLT. Glycine 
and tryptophan are higher in egkHLT. Mann-Whitney U-Test indicated that differences in 
aspartic acid, isoleucine, leucine, lysine, tryptophan, tyrosine, valine and the amino acid 
total were statistically significant (p≤0.05). 
 
 
Table 3.1 Short Chain Fatty Acid Results 
Table 3.4 shows SCFAs quantification results in fractional values of 
egkHLT and usKHLT, standard error values, and results of Mann-Whitney 
U test (p-values, bolded numbers are statistically significant).  
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Table 3.5: Amino acids quantification results  
 
Other metabolites 
 Table 3.6 shows the quantified (arbitrary units respective to TSP) values of the 
other metabolites looked at in our data set. Metabolites that are higher in egkHLT include 
cytosine, glucose, hypoxanthine, and uracil. Metabolites higher in uskHLT are 1-
methylhistamine, bile acids, choline, ethanol, fumarate, galactose, lactate, malate, 
methylamine, pyruvate, succinate, sucrose, taurine, and trimethylamine. Mann-Whitney 
U-Test indicated that differences bile acids, choline, ethanol, hypoxanthine, lactate, 
malate, methylamine, pyruvate, succinate, sucrose, taurine, and uracil were statistically 
significant (p≤0.05). 
 
 
 
 
Metabolite egkHLT ±SE uskHLT ±SE Mann-Whitney U Test 
Alanine 1.97 0.19 2.41 0.18 0.078 
Aspartic Acid  0.35 0.02 0.73 0.06 0.000 
Glycine 0.67 0.08 0.51 0.11 0.311 
Isoleucine 0.50 0.05 1.01 0.11 0.001 
Leucine 0.66 0.07 1.41 0.16 0.000 
Lysine 2.01 0.27 3.68 0.47 0.001 
Tryptophan 0.78 0.08 0.56 0.06 0.048 
Tyrosine 0.28 0.03 0.58 0.05 0.000 
Valine 0.14 0.01 0.28 0.04 0.000 
Total 7.57 0.64 11.43 0.74 0.001 
Table 3.5 shows amino acid quantification results in fractional values of egkHLT and 
usKHLT, standard error values, and results of Mann-Whitney U test (p-values, 
bolded numbers are statistically significant).  
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Table 3.6: Metabolites quantification results  
 
Figure 3.4 shows the comparison of select metabolites that differed between 
groups. All the SCFAs are grouped showing a higher percentage in egkHLT (83%) 
compared to uskHLT (75%). All the amino acids are grouped showing a higher 
percentage in uskHLT (11%) compared to egkHLT (8%). Bile acids, choline, and taurine 
are all grouped because of their involvement with bile acids and are higher in uskHLT 
(0.13%, 0.09%, 1.49%) compared to egkHLT (0.04%, 0.04%, 0.7%), respectively. 
Galactose, glucose, and sucrose were also grouped because they are all sugars. Galactose 
and sucrose are higher in uskHLT (0.18%, 0.94%) compared to egkHLT (0.09%, 0.42%). 
Glucose is higher in egkHLT (1.34%) compared to uskHLT (1.02%). 
Metabolite egkHLT ±SE uskHLT ±SE Mann-Whitney U Test 
1-Methylhistamine 0.90 0.10 1.28 0.21 0.122 
Bile Acids 0.04 0.00 0.13 0.05 0.006 
Choline  0.04 0.01 0.09 0.02 0.001 
Cytosine 0.81 0.08 0.58 0.06 0.066 
Ethanol 0.60 0.07 1.34 0.34 0.002 
Fumarate 0.08 0.01 0.12 0.02 0.364 
Galactose 0.09 0.01 0.18 0.12 0.575 
Glucose 1.34 0.16 1.02 0.22 0.311 
Hypoxanthine 0.56 0.06 0.32 0.04 0.002 
Lactate 0.85 0.05 1.30 0.12 0.005 
Malate 0.99 0.09 1.59 0.25 0.010 
Methylamine 0.18 0.01 0.24 0.02 0.015 
Pyruvate 0.09 0.01 0.21 0.03 0.000 
Succinate 0.30 0.09 1.27 1.13 0.013 
Sucrose 0.42 0.06 0.94 0.17 0.004 
Taurine 0.65 0.06 1.49 0.27 0.001 
Trimethylamine 0.08 0.01 0.08 0.01 0.790 
Uracil 0.75 0.08 0.46 0.05 0.022 
Table 3.6 shows metabolite quantification results in fractional values of egkHLT and 
usKHLT, standard error values, and results of Mann-Whitney U test (p-values, 
bolded numbers are statistically significant).  
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Figure 3.4: Fractional abundance percentages of metabolites 
 
 
 
 
 
 
 
 
 
 
 
 
Metabolite validation  
 Figures 3.5-3.11 show uskHLT31 spectrum before any addition of metabolite 
solutions and the spectra after the metabolite solutions were added. The spike-ins 
confirmed peak assignments that were located in crowded regions of the 
1
H NMR 
egkHLT/uskHLT spectra. Validations were successful and yielded the expected peaks 
based on a database search (HMBD).  
 
 
 
 
Figure 3.4 shows fractional abundance percentages of selected metabolite 
quantification results, egkHLT (red) and uskHLT (green). Groups include 
SCFAs, amino acids, compounds involved with bile acids, and sugars.  
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Figure 3.5: Galactose validation  
 
 
Figure 3.6: Glucose validation  
 
Figure 3.5 shows galactose validation through the spike-in procedure. The black line is the 
spectrum before the metabolite solution was added and the red line is after. 
Figure 3.6 shows glucose validation through the spike-in procedure. The black line is the 
spectrum before the metabolite solution was added and the red line is after. 
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Figure 3.7: Methylamine validation  
 
 
Figure 3.8: Sucrose validation  
 
Figure 3.7 shows methylamine validation through the spike-in procedure. The black line is 
the spectrum before the metabolite solution was added and the red line is after. 
Figure 3.8 shows sucrose validation through the spike-in procedure. The black line is the 
spectrum before the metabolite solution was added and the red line is after. 
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Figure 3.9: Isoleucine and leucine validation  
Figure 3.10: Uracil validation  
 
 
 
 
 
 
 
Figure 3.9 shows isoleucine and leucine validation through the spike-in procedure. The black 
line is the spectrum before the metabolite solution was added and the red line is after. 
Figure 3.10 shows uracil validation through the spike-in procedure. The black line is the 
spectrum before the metabolite solution was added and the red line is after. 
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Figure 3.11: Tryptophan validation  
 
 
 
 
 
 
 
 
 
 
Figure 3.11 shows Tryptophan validation through the spike-in procedure. The black line is the 
spectrum before the metabolite solution was added and the red line is after. The peak that was 
validated is at 7.54 ppm 
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Ordination analyses of metabolite data 
Principle component analysis  
Figure 3.12 shows PCA carried out in MATLAB R2014a. This model 
demonstrates that there is enough variability within the measured metabolites levels that 
can two distinct clusters that correspond to nationality of groups. The model's p-value (p< 
0.001) is statistically significant.  
Figure 3.12: PCA plot of metabolite data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p<0.001 
Figure 3.12 is the plot of principle components analysis of egkHLT 
(red) and uskHLT (green) samples. This data is based on the 
quantified metabolite data. 
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Orthogonal projection to latent structure discriminate analysis  
Figure 3.13 shows the OPLS-DA model with large group separation of T and little 
separation of T orthogonal. The model demonstrates that the metabolite variability in 
samples is separated into two groups and samples were placed in the correct groups. The 
model's p-value (p < 0.001) is statistically significant. The Q
2
 value was 0.73 meaning the 
model had predictive ability.  
Figure 3.13: OPLS-DA plot of metabolite data 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
p<0.001 
Figure 3.13 is the plot of orthogonal projection to latent structure 
discriminate analysis of egkHLT (red) and uskHLT (green) samples. 
This data is based on the quantified metabolite data. 
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Random forest  
Figure 3.14 shows Random forest ability to classify samples based on variability 
in metabolite levels into nationalities. RF also determined metabolites that are important 
for separation of the two nationalities. The mean decrease gini is the importance of each 
variable in classifying the data. The top 12 important metabolites are shown in Table 3.7, 
uracil has the highest score 
Figure 3.14: Random forest plot 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 is the plot of random forest of egkHLT (red) and uskHLT 
(green) samples. This data is based on quantified metabolite data. 
p<0.001 
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Table 3.7: Mean decrease gini scores 
Metabolites  
Mean Decrease 
Gini 
Uracil 2.5 
Tryptophan 2.3 
Cytosine 2.0 
Hypoxanthine 1.7 
Propionate 1.0 
Acetate 1.0 
Aspartic Acid  0.7 
Choline  0.6 
Leucine 0.6 
Butyrate 0.5 
Formate 0.4 
Isoleucine 0.4 
 
SparCC 
 Correlation analysis provided by SparCC demonstrated positive and negative 
correlations among metabolites and provided information about correlations between 
groups of metabolites. Table 3.8 shows the negative correlations between all metabolites 
(≤ -0.3 and p ≤ 0.01). Table 3.9 shows positive correlations between all metabolites (≥ 
0.3 and p ≤ 0.01). Table 3.10 shows the correlations between SCFAs and based on their 
median (0.41) they are positively correlated among each other. Table 3.11 shows the 
correlations between the amino acids and based on their median (0.17) they are positively 
correlated among each other. Table 3.12 shows the correlations between the amino acids, 
tryptophan and glycine, and based on their median (0.18) they are positively correlated. 
These two are grouped separately because they are higher in egkHLT. Table 3.13 shows 
the correlations between nucleotides (uracil, cytosine) and a nucleotide pre-cursor 
(hypoxanthine) and based on their median (0.40) they are positively correlated among 
each other. Table 3.14 shows the correlations between metabolites involved in 
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carbohydrate metabolites and based on their median (-0.4) they are negatively correlated. 
Table 3.15 shows the correlations between sugars and based on their median (0.08) they 
are positively correlated. Table 3.16 shows the correlations between other metabolites in 
the data set and based on their median (0.01) they are positively correlated. Table 3.17 
show the correlations between different groups of metabolites. It shows positive 
correlations between glycine/tryptophan and SCFAs (0.08), nucleotides and SCFAs 
(0.11), metabolites involved in carbohydrate metabolism and SCFAs (0.01), and 
metabolites involved in carbohydrate metabolism and amino acids (0.03). It shows 
negative correlations between SCFAs and amino acids (-0.11), glycine/tryptophan and 
amino acids (-0.07), nucleotides and amino acids (-0.02), sugars and SCFAs (-0.04), 
sugars and amino acids (-0.12), other metabolites and SCFAs (-0.07), and other 
metabolites and amino acids (-0.01). 
Table 3.8: Negative SparCC correlations 
Negative Correlations (≤ -0.3) 
Metabolites Correlated SparCC Value 
formate →  taurine -0.35 
glucose → lactate -0.36 
glycine → lactate -0.40 
glucose → leucine -0.36 
glycine → leucine -0.35 
glucose → valerate -0.49 
glycine → valerate -0.46 
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Table 3.9: Positive SparCC correlations 
Positive Correlations ( ≥ 0.3) 
Metabolites Correlated SparCC Value 
1-methylhistamine →  glycine 0.39 
1-methylhistamine → taurine 0.51 
acetate → butyrate 0.73 
acetate → propionate 0.84 
alanine → leucine 0.45 
butyrate → propionate 0.71 
formate → propionate 0.33 
glucose  → glycine 0.81 
isoleucine → leucine 0.55 
lactate → leucine 0.34 
lactate → valerate 0.40 
lysine → taurine 0.33 
propionate → valerate 0.34 
uracil → tryptophan 0.57 
 
Table 3.10: SCFAs SparCC correlations 
SCFAs Correlation  
Metabolites Correlated SparCC Value 
acetate → butyrate 0.73 
acetate → propionate 0.84 
acetate → formate 0.21 
acetate → valerate 0.16 
butyrate → propionate 0.71 
butyrate → formate 0.18 
butyrate → valerate 0.34 
formate → propionate 0.33 
formate → valerate 0.20 
propionate → valerate 0.37 
Median 0.41 
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Table 3.11: Amino acid SparCC correlations  
Amino Acid Correlations 
Metabolites Correlated SparCC Value 
alanine → aspartic acid -0.05 
alanine → isoleucine 0.41 
alanine → leucine 0.45 
alanine → lysine 0.38 
alanine → tyrosine 0.27 
alanine → valine -0.02 
aspartic acid → isoleucine 0.16 
aspartic acid → leucine 0.15 
aspartic acid → lysine 0.15 
aspartic acid → tyrosine 0.10 
aspartic acid → valine 0.03 
isoleucine → leucine 0.55 
isoleucine → lysine 0.21 
isoleucine → tyrosine 0.38 
isoleucine → valine 0.14 
leucine → lysine 0.27 
leucine → tyrosine 0.46 
leucine → valine  0.17 
lysine → tyrosine 0.17 
lysine → valine 0.03 
tyrosine → valine 0.05 
Median 0.17 
 
Table 3.12: Tryptophan and glycine SparCC 
Tryptophan and Glycine Correlations 
Metabolites Correlated SparCC Value 
tryptophan → glycine 0.18 
Median 0.18 
 
Table 3.13: Nucleotide SparCC correlations  
Nucleotide Correlations 
Metabolites Correlated SparCC Value 
cytosine → hypoxanthine 0.40 
cytosine → uracil 0.59 
hypoxanthine → uracil 0.40 
Median 0.40 
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Table. 3.14: Carbohydrate metabolism SparCC correlations  
Carbohydrate Metabolism 
Metabolites Correlated SparCC Value 
ethanol → fumarate 0.07 
ethanol → lactate -0.04 
ethanol → malate -0.09 
ethanol → pyruvate 0.29 
ethanol → succinate 0.03 
fumarate → lactate -0.10 
fumarate → malate -0.07 
fumarate → pyruvate -0.02 
fumarate → succinate -0.10 
lactate → malate -0.21 
lactate → pyruvate 0.22 
lactate → succinate -0.25 
malate → pyruvate -0.05 
malate → succinate 0.03 
pyruvate → succinate -0.04 
Median -0.04 
 
Table. 3.15: Sugars SparCC correlations  
Sugars Correlations 
Metabolites Correlated SparCC Value 
galactose → glucose 0.24 
galactose → sucrose 0.08 
glucose → sucrose -0.04 
Median 0.08 
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Table. 3.16: Other metabolite SparCC correlations  
Other Metabolite Correlations 
Metabolites Correlated SparCC Value 
1-methylhistamine → bile acids 0.12 
1-methylhistamine → choline  -0.04 
1-methylhistamine → methylamine 0.14 
1-methylhistamine → taurine 0.51 
1-methylhistamine → trimethylamine -0.05 
bile acids → choline 0.03 
bile acids → methylamine 0.00 
bile acids → taurine 0.06 
bile acids → trimethylamine -0.09 
choline → methylamine -0.04 
choline → taurine -0.01 
choline → trimethylamine 0.01 
methylamine→ taurine 0.11 
methylamine → trimethylamine -0.02 
taurine → trimethylamine -0.06 
Median  0.01 
 
Table 3.17: Correlations between different groups of metabolites 
Correlations Between Groups 
Metabolites Correlated Median 
SCFAs → amino acids -0.11 
nucleotides → SCFAs 0.11 
nucleotides → amino acids -0.02 
glycine/tryptophan → SCFAs 0.08 
glycine/tryptophan → amino acids -0.07 
carbohydrate metabolism→ SCFAs 0.01 
carbohydrate metabolism → amino acids 0.03 
sugars → SCFAs -0.04 
sugars → amino acids -0.12 
other metabolites → SCFAs -0.07 
other metabolites → amino acids -0.01 
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Figure 3.15 demonstrates the correlation network of the metabolite data. SCFAs are 
correlated positively among each other and negatively between amino acids. Nucleotides 
are correlated positively among each other and positively between SCFAs. Amino acids 
are positively correlated among each other, except glycine and tryptophan which are 
negatively correlated to the other amino acids. Although a lot of these correlations are 
weak it gives us a better understanding as to what metabolites might interact with each 
other and their possible influence on each other.  
Figure 3.15: SparCC correlation network 
Figure 3.15 demonstrates the correlation network based on statistically significant 
SparCC values. Red lines are positive correlations and green lines are negative 
correlations. Saturation of the line corresponds to the strength of the correlation. The 
boxes represent metabolites and their abundance (lighter purple = less abundant, darker 
purple = more abundant) within the data set.  
*Image was created by V. Shankar 
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4. Discussion  
 This work aimed to determine if there is a difference in metabolite profiles of 
fecal material collected from adolescents in two distinct geographical locations. Using 
1
H 
NMR, egkHLT and uskHLT fecal metabolite levels were quantified and compared. 
Differences are thought to be an effect of diet differences of the Egyptian population and 
US population. These metabolite differences may cause certain health effects on the host. 
 
Sample ordination analyses 
 Ordination analyses of the binned NMR data showed that the samples formed two 
distinct groups and could be classified based on nationality. Ordination analyses of 
metabolite data demonstrated that variability within the quantified metabolites formed 
two distinct clusters and samples could be classified based on nationality. Quantified 
metabolite data analyses also showed that uracil was the most important metabolite for 
classifying the data. Correlation analysis by SparCC showed positive and negative 
correlations within the metabolite data set. It also showed inter and intra correlations 
among the following groups: SCFAs, amino acids, tryptophan and glycine, carbohydrate 
metabolism metabolites, sugars, and the other metabolites in the data set.  
 
Differences in Metabolite Levels Between egkHLT and uskHLT 
 The data shows that levels of SCFAs are higher in egkHLT compared to uskHLT. 
This may be due to the high intake of dietary fiber in the Egyptian diet. Egyptians have 
been shown to intake around 31g per day of fiber [61]. Dietary fiber is found in foods 
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such as whole grains, legumes, fruits, and vegetables [62]. The Egyptian’s diet main food 
staples are bread made from high extraction wheat flour, cereals, legumes, and fresh dark 
leafy green vegetables [47]. The dietary fiber acquired from these foods can be converted 
into SCFAs in the colon by bacteria. In the United States, the recommended amount of 
dietary fiber is around 25g per day for women and 38g per day for men. However, 
Americans are only consuming around 15g per day [62]. This difference in dietary fiber 
intake could be a major contributor to the difference between the egkHLT/uskHLT fecal 
metabolite levels. SCFAs have been shown to have important anti-inflammatory effects 
which could potentially be used as therapies for gastrointestinal inflammatory diseases 
such as IBD [24]. 
The levels of almost all amino acid levels were higher in the uskHLT samples.  
This may also be linked to diet differences and the high amount of protein found in foods 
such as meats. According to an article about trends in meat consumption in the United 
States, children ages 12-19 consumed 121.8g per day of meat products [29]. Meat in take 
in Egypt is only around 72g per day [61]. Meat consumptions may be lower because it is 
a luxury item and religious and cultural observations prevent some Egyptians from eating 
meat at certain times [47]. This high meat consumption in the United States could play a 
key role in the development of several health diseases such as colorectal cancer [28].  
Another difference shown in our data is that the amino acid tryptophan is higher 
in egkHLT compared to uskHLT. Tryptophan is high in foods such as seeds, legumes, 
soy protein, dairy products, and animal protein [63]. In a study done by Young et. al., 
they showed that tryptophan is slightly higher in plant protein sources (nuts, seeds, and 
legumes) than in animal protein [64]. In the US only around 30% of protein intake comes 
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from plants where as almost 70% comes from animal protein. However, in Africa and 
Middle East around 14% of protein intake is animal and around 79% is plant [64]. This 
could account for the levels of tryptophan being higher in egkHLT. 
 Other metabolites also show a difference between egkHLT and uskHLT. For 
example, bile acids are higher in uskHLT. Bile acids are increased during high fat intake 
and high fat foods seem to be consumed more in the US diet [32]. The Dietary Guidelines 
for American’s say that adolescents should only consume 30% of calories from fat and 
only 10% of that fat from saturated fats [65]. A study by Reedy et. al., determined based 
on National Health and Nutrition Examination Survey (NHANES) showed that 40% of 
total energy (798 of the 2,027 kcal per day) consumed by 2-18 year olds, came from solid 
fat and added sugars. The major sources of these fats were from pizza, grain desserts, 
whole milk, cheese, and fatty meats [66]. Egyptian diet tends to be lower in saturated fats 
[47]. In a study done by Galal, dietary energy from fat in Egypt was 28.7% for children, 
and primarily came from vegetable oil in mixed dishes [67]. This is almost 10% lower 
than US adolescents and could account for the difference in levels of bile acids. Increased 
bile acid levels have been linked to a variety of cancers in humans [32]. 
 Another metabolite found higher in uskHLT samples was taurine. Taurine is 
present in many foods and is high in foods such as meat, fish, and energy drinks. Meat 
and fish can contain anywhere from 300-6000 mol per 100g per wet weight of taurine. 
As where fruits, vegetables, nuts, and legumes contain ranges less than 1 mol per 100g 
per wet weight [36]. Meat consumption as mentioned above seems to be more prevalent 
in the United States diet. Another source of taurine in the United States diet is through 
energy drinks. Energy drinks are a billion dollar business in the United States and half of 
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the market is consumed by adolescents (< 12, 12-18 years old) and young adults (19-25 
years old) [37]. Energy drinks which usually come in 16 or 24 oz cans, can contain up to 
1,000 mg of taurine in an 8.0-8.4 ounce serving [68]. According to one article, thirty-one 
percent of energy drink consumers are ages 12-17 years old and 28 percent of 12-14 year 
olds report to regularly consume energy drinks, which is the average age of the uskHLT 
cohort [69]. The high consumption of meat and energy drinks could account for the 
higher amount of taurine in the uskHLT samples. Over consumption of taurine can cause 
adverse effects such as increased heart rate and hypoglycemia [37]. 
 Choline was also found to be higher in uskHLT. Choline is rich in foods such as 
eggs, liver, and peanuts. In the US diet the major contributors of choline includes meat, 
poultry, egg-based dishes, and dairy foods [70]. Choline can also be found in wheat and 
spinach, which are main staples in the Egyptian diet [70]. However, high meat intake as 
mentioned before in the US diet could be the reason for the slight increase choline levels 
in uskHLT. Choline deficiency has been linked to liver and muscle dysfunction [39]. 
 
Connections to previous studies 
 Previous studies have shown a link in diet and metabolite differences among 
different groups of people. However, most of these studies focus on specific groups of 
metabolites and use techniques other than NMR for metabolite quantification. For 
example, as mentioned in the introduction an article by De Flippo et. al. compared levels 
of SCFAs between an African group of adolescents from Burkina Faso (BF) and 
European adolescents from Florence, Italy (EU) [45]. The researchers believed that diet 
differences caused changes in the microbiota composition and this resulted in the higher 
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amount of SCFAs in the BF cohort. The SCFAs quantifications were determined by mass 
spectrometry [45]. Another study compared individuals on two different short-term diets, 
one consisting of plant-based foods and one of animal product based foods. Using gas 
chromatography and mass spectrometry they determined that people on the animal-based 
diet had higher levels of bile acids (specifically DCA) and people on the plant-based diet 
had higher levels of SCFAs [71]. These examples prove that diet differences can be 
linked to differences in metabolites and we wanted to expand on that concept by looking 
at more metabolites using the nondestructive and noninvasive technique of NMR.  
 
Conclusion 
 
1
H NMR analysis on fecal material has been previously shown by researchers as a 
valuable tool to determine metabolite profiles [39, 40]. This study confirms this approach 
and concludes that there are differences in metabolite profiles between Egyptian and US 
adolescents. Major differences include, SCFAs being higher in egkHLT samples and 
most amino acids being higher in uskHLT samples. These differences in metabolite 
levels is thought to be due to the varying diets of the two populations. Based on a 
literature, I was able to link certain metabolites to dietary products and determine their 
involvement with human health. Although my analysis is limited to fecal material and 32 
metabolites, my hope is that other researchers can use the same concepts and methods to 
look at other parameters (blood, urine) and gain a more comprehensive profile of 
metabolites between individuals. I also hope this work can help scientist and medical 
professionals gain a better knowledge as to what foods influence metabolite profiles and 
how this could promote or be detrimental to human health. 
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